Sarah L. Huszar

621 total citations
12 papers, 400 citations indexed

About

Sarah L. Huszar is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Pharmacology. According to data from OpenAlex, Sarah L. Huszar has authored 12 papers receiving a total of 400 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 7 papers in Cellular and Molecular Neuroscience and 4 papers in Pharmacology. Recurrent topics in Sarah L. Huszar's work include Neuroscience and Neuropharmacology Research (7 papers), Receptor Mechanisms and Signaling (6 papers) and Tryptophan and brain disorders (3 papers). Sarah L. Huszar is often cited by papers focused on Neuroscience and Neuropharmacology Research (7 papers), Receptor Mechanisms and Signaling (6 papers) and Tryptophan and brain disorders (3 papers). Sarah L. Huszar collaborates with scholars based in United States, France and Poland. Sarah L. Huszar's co-authors include Jason M. Uslaner, Joshua D. Vardigan, Sean M. Smith, Peter H. Hutson, Caitlyn McNaughton, Lihang Yao, Monika Kandebo, John J. Renger, Pete H. Hutson and Marlene A. Jacobson and has published in prestigious journals such as Journal of Medicinal Chemistry, Journal of Pharmacology and Experimental Therapeutics and Psychopharmacology.

In The Last Decade

Sarah L. Huszar

12 papers receiving 395 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sarah L. Huszar United States	10	239	179	73	69	60	12	400
Waisi Eng United States	13	250 1.0×	311 1.7×	51 0.7×	44 0.6×	16 0.3×	29	557
Monika Kandebo United States	10	175 0.7×	76 0.4×	79 1.1×	63 0.9×	41 0.7×	12	294
Linda M. Pullan United States	15	382 1.6×	289 1.6×	45 0.6×	81 1.2×	25 0.4×	29	609
József Barkóczy Hungary	16	292 1.2×	264 1.5×	74 1.0×	23 0.3×	23 0.4×	31	709
Gabriella Gentile Italy	12	218 0.9×	166 0.9×	35 0.5×	20 0.3×	19 0.3×	35	445
Andrew S. Felts United States	20	447 1.9×	385 2.2×	101 1.4×	23 0.3×	25 0.4×	35	796
Tomoko Kuno Japan	10	321 1.3×	274 1.5×	38 0.5×	28 0.4×	14 0.2×	17	487
Danette Pascarella United States	6	341 1.4×	354 2.0×	28 0.4×	118 1.7×	70 1.2×	6	528
Weimin Hong United States	13	562 2.4×	479 2.7×	68 0.9×	19 0.3×	33 0.6×	24	785
Bryan Johnson United States	8	166 0.7×	97 0.5×	42 0.6×	51 0.7×	36 0.6×	14	364

Countries citing papers authored by Sarah L. Huszar

Since Specialization

Citations

This map shows the geographic impact of Sarah L. Huszar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah L. Huszar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah L. Huszar more than expected).

Fields of papers citing papers by Sarah L. Huszar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah L. Huszar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah L. Huszar. The network helps show where Sarah L. Huszar may publish in the future.

Co-authorship network of co-authors of Sarah L. Huszar

This figure shows the co-authorship network connecting the top 25 collaborators of Sarah L. Huszar. A scholar is included among the top collaborators of Sarah L. Huszar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah L. Huszar. Sarah L. Huszar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Layton, M. E., Jeffrey C. Kern, William D. Shipe, et al.. (2023). Discovery of MK-8189, a Highly Potent and Selective PDE10A Inhibitor for the Treatment of Schizophrenia. Journal of Medicinal Chemistry. 66(2). 1157–1171. 22 indexed citations

Rossi, Michael, Michael J. Kelly, M. E. Layton, et al.. (2016). Optimization of Novel Aza-benzimidazolone mGluR2 PAMs with Respect to LLE and PK Properties and Mitigation of CYP TDI. ACS Medicinal Chemistry Letters. 7(3). 312–317. 8 indexed citations

Layton, M. E., Vadim Dudkin, Michael J. Kelly, et al.. (2016). Discovery of 5-aryl-1,3-dihydro-2H-imidazo[4,5-b]pyridin-2-ones as positive allosteric modulators of metabotropic glutamate subtype-2 (mGlu2) receptors with efficacy in a preclinical model of psychosis. Bioorganic & Medicinal Chemistry Letters. 26(4). 1260–1264. 7 indexed citations

Smith, Sean M., Jason M. Uslaner, Christopher D. Cox, et al.. (2012). The novel phosphodiesterase 10A inhibitor THPP-1 has antipsychotic-like effects in rat and improves cognition in rat and rhesus monkey. Neuropharmacology. 64. 215–223. 70 indexed citations

Raheem, Izzat T., Michael J. Breslin, Christine Fandozzi, et al.. (2012). Discovery of tetrahydropyridopyrimidine phosphodiesterase 10A inhibitors for the treatment of schizophrenia. Bioorganic & Medicinal Chemistry Letters. 22(18). 5903–5908. 25 indexed citations

Deschamps, Kathleen, Wanda Cromlish, Sean Weicker, et al.. (2010). Genetic and Pharmacological Evaluation of Cathepsin S in a Mouse Model of Asthma. American Journal of Respiratory Cell and Molecular Biology. 45(1). 81–87. 39 indexed citations

Brnardic, Edward J., Mark E. Fraley, R. M. Garbaccio, et al.. (2010). 3-Aryl-5-phenoxymethyl-1,3-oxazolidin-2-ones as positive allosteric modulators of mGluR2 for the treatment of schizophrenia: Hit-to-lead efforts. Bioorganic & Medicinal Chemistry Letters. 20(10). 3129–3133. 30 indexed citations

Garbaccio, R. M., Edward J. Brnardic, Mark E. Fraley, et al.. (2010). Discovery of Oxazolobenzimidazoles as Positive Allosteric Modulators for the mGluR2 Receptor. ACS Medicinal Chemistry Letters. 1(8). 406–410. 14 indexed citations

Vardigan, Joshua D., Sarah L. Huszar, Caitlyn McNaughton, Peter H. Hutson, & Jason M. Uslaner. (2010). MK-801 produces a deficit in sucrose preference that is reversed by clozapine, d-serine, and the metabotropic glutamate 5 receptor positive allosteric modulator CDPPB: Relevance to negative symptoms associated with schizophrenia?. Pharmacology Biochemistry and Behavior. 95(2). 223–229. 60 indexed citations

10.

Uslaner, Jason M., Sean M. Smith, Sarah L. Huszar, et al.. (2010). T-type calcium channel antagonism produces antipsychotic-like effects and reduces stimulant-induced glutamate release in the nucleus accumbens of rats. Neuropharmacology. 62(3). 1413–1421. 27 indexed citations

11.

Uslaner, Jason M., et al.. (2009). Combined administration of an mGlu2/3 receptor agonist and a 5-HT2A receptor antagonist markedly attenuate the psychomotor-activating and neurochemical effects of psychostimulants. Psychopharmacology. 206(4). 641–651. 25 indexed citations

12.

Smith, Sean M., Jason M. Uslaner, Lihang Yao, et al.. (2008). The Behavioral and Neurochemical Effects of a Novel d-Amino Acid Oxidase Inhibitor Compound 8 [4 H-Thieno [3,2-b]pyrrole-5-carboxylic Acid] and d-Serine. Journal of Pharmacology and Experimental Therapeutics. 328(3). 921–930. 73 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact